FutureFuel (FF) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
6 Jun, 2025Executive summary
Revenue for Q1 2025 declined 70% year-over-year to $17.5M, driven by lower sales volumes in both biofuels and chemicals due to an extended plant turnaround, severe weather, and weaker biodiesel margins.
Net loss was $17.6M ($0.40 per diluted share) compared to net income of $4.3M ($0.10 per share) in Q1 2024, with both segments reporting gross losses.
Adjusted EBITDA was negative $16.1M, a $23.2M decrease from the prior year period.
The expiration of the biodiesel Blenders' Tax Credit (BTC) and uncertainty around the Clean Fuel Production Credit (CFPC) further pressured results.
Plant maintenance in Batesville, AR, was advanced to address margin weakness, with operations resuming in March.
Financial highlights
Revenue: $17.5M, down from $58.3M year-over-year.
Net loss: $17.6M, compared to net income of $4.3M in Q1 2024.
Gross loss: $14.6M, versus gross profit of $5.0M in Q1 2024.
Adjusted EBITDA: $(16.1)M, down from $7.1M.
Cash and cash equivalents: $97.1M as of March 31, 2025, down from $109.5M at year-end 2024.
Outlook and guidance
Backward-integrated capacity project on track for late summer 2025 completion, expected to contribute revenue by Q3 2025.
Management expects to recognize $4.0M in revenue from remaining performance obligations over the next two to six years, with 21% in the next 12 months.
Management expects industry recovery as less-efficient biodiesel capacity exits and regulatory clarity improves.
Existing cash, cash flow, and a $75M credit facility are expected to fund operations and capital needs for the foreseeable future.
Continued investment in growth and operational efficiency to capture superior economics during recovery.
Latest events from FutureFuel
- 2025 saw steep losses and revenue declines, but new plant investments and regulatory clarity support a 2026 rebound.FF
Q4 202516 Mar 2026 - Annual meeting to elect directors, ratify auditor, and update governance and compensation.FF
Proxy Filing2 Dec 2025 - Shareholders will elect directors, ratify a new auditor, and see board and leadership changes.FF
Proxy Filing2 Dec 2025 - Q3 2025 revenue dropped 56% with a $9.3M net loss amid biofuel market and regulatory headwinds.FF
Q3 202510 Nov 2025 - Q2 2025 revenue fell 51% and net loss reached $10.4M as biodiesel production was idled.FF
Q2 202511 Aug 2025 - Q3 loss and cash decline driven by biofuel weakness, margin pressure, and special dividend.FF
Q3 202413 Jun 2025 - Q2 net income reached $9.6M as margins improved despite lower revenue and market pressures.FF
Q2 202413 Jun 2025 - 2024 saw steep profit declines from biofuel headwinds, but chemicals showed resilience.FF
Q4 20245 Jun 2025